150314-35-5CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NCCOFMVHVRYFQIXOAF-DOFZRALJSA-N7,10,13,16-Docosatetraenoylethanolamine is a N-acylethanolamine 22:4.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
DescriptionDocosatetraenoyl ethanolamide (DEA) is an endocannabinoid containing docosatetraenoic acid in place of the arachidonate moiety of AEA. DEA acts on CB1 receptors with potency and efficacy similar to that of AEA. However, its specific role and relative importance as a cannabinergic neurotransmitter have not been elucidated.
Uses(7Z,10Z,13Z,16Z)-N-(2-Hydroxyethyl)-7,10,13,16-docosatetraenamide is an endocannabinoid and an analog of anandamide, which is an endogenous cannabinoid and TRPV1 receptor agonist.
DefinitionChEBI: 7,10,13,16-Docosatetraenoylethanolamine is a N-acylethanolamine 22:4.
Loading…
Loading…
No reaction records under the current filter.
Loading…
150314-35-5DTXSID501028460CHEMBL321585CHEBI:34478